A peripherally inserted central catheter offers a secure and
reliable method of venous access for patients newly diagnosed
with acute promyelocytic leukaemia

J 2026

A peripherally inserted central catheter offers a secure and reliable method of venous access for patients newly diagnosed with acute promyelocytic leukaemia

SZOTKOWSKI, Tomas; Martin CERNAN; Ladislav SOPKO; Štěpán HRABOVSKÝ; Tomas PROCHAZKA et al.

Základní údaje

Originální název

A peripherally inserted central catheter offers a secure and reliable method of venous access for patients newly diagnosed with acute promyelocytic leukaemia

Autoři

Vydání

JOURNAL OF VASCULAR ACCESS, LONDON, SAGE PUBLICATIONS LTD, 2026, 1129-7298

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30205 Hematology

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 1.700 v roce 2024

Označené pro přenos do RIV

Ano

Organizační jednotka

Lékařská fakulta

Klíčová slova anglicky

Peripherally inserted central catheter; acute promyelocytic leukaemia; venous access; catheter-related bloodstream infection; catheter-related thrombosis

Štítky

14110212, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 26. 2. 2026 11:20, Mgr. Tereza Miškechová

Anotace

V originále

Introduction: Newly diagnosed acute promyelocytic leukaemia (APL) poses a significant bleeding risk. Current treatment guidelines advise against invasive procedures, such as central venous catheter placement. However, ensuring safe intravenous administration of both anti-leukaemic and supportive therapies is critical.Methods: This retrospective observational study examines real-world experiences with peripherally inserted central catheters (PICCs) in 84 newly diagnosed APL patients who received PICCs within the first week after diagnosis.Results: Of the 84 PICCs, 38 (45%) remained in situ for the full duration of treatment, while 36 (43%) were removed prematurely. The median PICC dwell time across the cohort was 139 days. No severe complications were reported following catheter implantation, and PICC use was not associated with mortality or permanent injury in any patient.Conclusion: These findings suggest that PICCs are a viable and safe option for venous access in APL patients, both during implantation and for extended use throughout treatment.

Citovat

SZOTKOWSKI, Tomas; Martin CERNAN; Ladislav SOPKO; Štěpán HRABOVSKÝ; Tomas PROCHAZKA; Zdenek KORISTEK; Jan VYDRA; Katerina ZIBRIDOVA; Balazs GALFFY; Adéla PRCHLÍKOVÁ; Pavel JINDRA; Juraj DURAS; Barbora CEMUSOVA; Pavel ZAK a Tomas PAPAJIK. A peripherally inserted central catheter offers a secure and reliable method of venous access for patients newly diagnosed with acute promyelocytic leukaemia. JOURNAL OF VASCULAR ACCESS. LONDON: SAGE PUBLICATIONS LTD, 2026, roč. 27, č. 2, s. 594-599. ISSN 1129-7298. Dostupné z: https://doi.org/10.1177/11297298251352693.

@article{2556863,
   author = {Szotkowski, Tomas and Cernan, Martin and Sopko, Ladislav and Hrabovský, Štěpán and Prochazka, Tomas and Koristek, Zdenek and Vydra, Jan and Zibridova, Katerina and Galffy, Balazs and Prchlíková, Adéla and Jindra, Pavel and Duras, Juraj and Cemusova, Barbora and Zak, Pavel and Papajik, Tomas},
   article_location = {LONDON},
   article_number = {2},
   doi = {https://doi.org/10.1177/11297298251352693},
   keywords = {Peripherally inserted central catheter; acute promyelocytic leukaemia; venous access; catheter-related bloodstream infection; catheter-related thrombosis},
   language = {eng},
   issn = {1129-7298},
   journal = {JOURNAL OF VASCULAR ACCESS},
   title = {A peripherally inserted central catheter offers a secure and reliable method of venous access for patients newly diagnosed with acute promyelocytic leukaemia},
   url = {https://journals.sagepub.com/doi/10.1177/11297298251352693},
   volume = {27},
   year = {2026}
}

TY  - JOUR
ID  - 2556863
AU  - Szotkowski, Tomas - Cernan, Martin - Sopko, Ladislav - Hrabovský, Štěpán - Prochazka, Tomas - Koristek, Zdenek - Vydra, Jan - Zibridova, Katerina - Galffy, Balazs - Prchlíková, Adéla - Jindra, Pavel - Duras, Juraj - Cemusova, Barbora - Zak, Pavel - Papajik, Tomas
PY  - 2026
TI  - A peripherally inserted central catheter offers a secure and reliable method of venous access for patients newly diagnosed with acute promyelocytic leukaemia
JF  - JOURNAL OF VASCULAR ACCESS
VL  - 27
IS  - 2
SP  - 594-599
EP  - 594-599
PB  - SAGE PUBLICATIONS LTD
SN  - 11297298
KW  - Peripherally inserted central catheter
KW  - acute promyelocytic leukaemia
KW  - venous access
KW  - catheter-related bloodstream infection
KW  - catheter-related thrombosis
UR  - https://journals.sagepub.com/doi/10.1177/11297298251352693
N2  - Introduction: Newly diagnosed acute promyelocytic leukaemia (APL) poses a significant bleeding risk. Current treatment guidelines advise against invasive procedures, such as central venous catheter placement. However, ensuring safe intravenous administration of both anti-leukaemic and supportive therapies is critical.Methods: This retrospective observational study examines real-world experiences with peripherally inserted central catheters (PICCs) in 84 newly diagnosed APL patients who received PICCs within the first week after diagnosis.Results: Of the 84 PICCs, 38 (45%) remained in situ for the full duration of treatment, while 36 (43%) were removed prematurely. The median PICC dwell time across the cohort was 139 days. No severe complications were reported following catheter implantation, and PICC use was not associated with mortality or permanent injury in any patient.Conclusion: These findings suggest that PICCs are a viable and safe option for venous access in APL patients, both during implantation and for extended use throughout treatment.
ER  -

SZOTKOWSKI, Tomas; Martin CERNAN; Ladislav SOPKO; Štěpán HRABOVSKÝ; Tomas PROCHAZKA; Zdenek KORISTEK; Jan VYDRA; Katerina ZIBRIDOVA; Balazs GALFFY; Adéla PRCHLÍKOVÁ; Pavel JINDRA; Juraj DURAS; Barbora CEMUSOVA; Pavel ZAK a Tomas PAPAJIK. A peripherally inserted central catheter offers a secure and reliable method of venous access for patients newly diagnosed with acute promyelocytic leukaemia. \textit{JOURNAL OF VASCULAR ACCESS}. LONDON: SAGE PUBLICATIONS LTD, 2026, roč.~27, č.~2, s.~594-599. ISSN~1129-7298. Dostupné z: https://doi.org/10.1177/11297298251352693.

Přehled o publikaci